Compare MRVI & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | SPH |
|---|---|---|
| Founded | 2014 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 1996 |
| Metric | MRVI | SPH |
|---|---|---|
| Price | $7.13 | $16.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $9.64 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 2.0M | 193.4K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 8.30% |
| EPS Growth | 14.29 | ★ 42.11 |
| EPS | N/A | ★ 2.48 |
| Revenue | $185,743,000.00 | ★ $1,432,518,000.00 |
| Revenue This Year | $15.38 | $3.58 |
| Revenue Next Year | $4.79 | $0.83 |
| P/E Ratio | ★ N/A | $6.78 |
| Revenue Growth | N/A | ★ 7.94 |
| 52 Week Low | $2.80 | $16.25 |
| 52 Week High | $9.42 | $20.80 |
| Indicator | MRVI | SPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 39.72 |
| Support Level | $6.54 | $16.39 |
| Resistance Level | $7.60 | $17.96 |
| Average True Range (ATR) | 0.51 | 0.36 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 28.62 | 12.32 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.